Dr. Gordon Ho, MD

Dr. Ho practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Ho's NPI, 1346516069, was assigned on March 27, 2012. Dr. Ho graduated from UC San Diego School of Medicine in 2010. Dr. Ho holds California license A117703.

Dr. Ho's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Ho's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Ho is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ho practices. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Dr. Ho's primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Dr. Ho is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Ho is licensed in California.

Dmand AI lists atrial fibrillation and flutter, heart blockage, intermittent racing heartbeat (PSVT), pacemaker or defibrillator implantation, pacemaker replacement, sick sinus syndrome and ventricular tachycardia among the conditions Dr. Ho treats.

CMS data shows 1,080 Medicare services from Dr. Ho across 13 procedure codes in 2024, for 629 Medicare patients. Medicare paid $44,376 for them.

CMS counts 629 Medicare patients who saw Dr. Ho in 2024. The largest group is 65 to 74, with 261 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ho's median patient age at 67, with 50% women.

In 2024, Dr. Ho wrote 360 Medicare Part D claims for 86 patients. 70% of them were for generic drugs. CMS names the drug for 304 of them, across 10 drugs with 11 or more claims each, at $142,707 in total drug cost. In 2023, CMS named 252 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Ho for performance year 2024, reported as part of a group. Dr. Ho accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ho as offering telehealth.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 48 papers to Dr. Ho, published from 2012 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Catheter Ablation, Atrial Fibrillation and Defibrillators, Implantable. Dr. Ho has published most often in J Interv Card Electrophysiol. Dr. Ho's most frequent co-authors are David Edward Krummen, MD, Gregory K. Feld, MD and Kurt Stephen Hoffmayer, MD.

Dmand AI links Dr. Ho to 1 clinical trial. Conditions studied include Atrial Premature Complexes and Tachycardia, Atrioventricular Nodal Reentry.

CMS Open Payments shows 215 general payments to Dr. Ho from 26 drug and device companies from 2016 to 2025. Grants make up the largest share, 40% of the total. Boston Scientific Corporation paid the most, $17,109.

Dr. Ho graduated from UC San Diego School of Medicine in 2010. Dr. Ho is a member of ACC, AHA and HRS.

Dr. Ho is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.